These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11784815)

  • 1. Despair of repair.
    Stangel M; Hartung HP
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):1-4. PubMed ID: 11784815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?].
    Schmidt S; Hohlfeld R
    Nervenarzt; 1995 Apr; 66(4):304-7. PubMed ID: 7783819
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple sclerosis.
    McKhann GM
    Annu Rev Neurosci; 1982; 5():219-39. PubMed ID: 6176172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of multiple sclerosis using hemolyzed blood of the patient].
    PRUSAK L
    Neurol Neurochir Psychiatr Pol; 1958; 8(2):173-6. PubMed ID: 13566370
    [No Abstract]   [Full Text] [Related]  

  • 5. An in-vitro approach to the study of oligodendrocytes and their involvement in multiple sclerosis.
    Szuchet S; Dumas M
    Neurol Clin; 1983 Aug; 1(3):729-55. PubMed ID: 6680171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of results of the treatment of multiple sclerosis with hemolyzed blood].
    KOZIK M; WENDER M
    Pol Tyg Lek (Wars); 1957 Aug; 12(35):1352-6. PubMed ID: 13505224
    [No Abstract]   [Full Text] [Related]  

  • 8. [New therapeutic strategies for remyelination in multiple sclerosis].
    Kremer D; Hartung HP; Stangel M; Küry P
    Nervenarzt; 2015 Aug; 86(8):934-46. PubMed ID: 26122637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of the treatment of disseminated sclerosis with antireticular cytotoxic serum according to A. Bogomoletz].
    CENDROWSKI W
    Pol Tyg Lek (Wars); 1958 Jan; 13(4):134-7. PubMed ID: 13542267
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diseases of the nervous system with patients hemolyzed blood with special reference to multiple sclerosis; preliminary communication].
    PRUSAK L
    Pol Tyg Lek (Wars); 1954 Nov; 9(46):1471-5. PubMed ID: 13236742
    [No Abstract]   [Full Text] [Related]  

  • 12. Caveat regarding immunoglobulin therapy in multiple sclerosis.
    Cross AH; Trotter JL; Hart WM
    Ann Neurol; 1993 Jun; 33(6):660-1. PubMed ID: 8338598
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic strategies in multiple sclerosis. II. Long-term repair.
    Scolding N
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1711-20. PubMed ID: 10603622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientists probe strategies to repair neuron damage in multiple sclerosis.
    Kuehn BM
    JAMA; 2011 Mar; 305(9):871-2, 874. PubMed ID: 21364130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development and regeneration of oligodendrocytes: therapeutic perspectives in demyelinating diseases].
    Dubois-Dalcq M
    Bull Mem Acad R Med Belg; 2005; 160(10-12):407-15; discussion 415-6. PubMed ID: 16768245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelination in multiple sclerosis: realizing a long-standing challenge.
    Aharoni R
    Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for achieving and monitoring myelin repair.
    Rice C; Scolding N
    J Neurol; 2007 Mar; 254(3):275-83. PubMed ID: 17345032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury.
    Labombarda F; González SL; Lima A; Roig P; Guennoun R; Schumacher M; de Nicola AF
    Glia; 2009 Jun; 57(8):884-97. PubMed ID: 19053058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of retrobulbar neuritis].
    Zavalishin IA; Zakharova MN; Dziuba AN; Khaĭdarov BT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):3-5. PubMed ID: 1326167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation.
    Sternberger NH; Itoyama Y; Kies MW; Webster HD
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2521-4. PubMed ID: 353815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.